Understanding how choices in chromatography solutions impact overall process efficiency.

Personalized medicine, digital therapeutics, and GLP-1s; experts tell us what areas are hot in pharma’s future.

We find out why Cas12l incorporated into a gene-writing system could help advance the field of gene editing.

Unethical practices and forced labor exist in HPMC supply chains. Here’s what can be done about it.

The essential roles of optimized cell lines and vectors in accelerating bioprocessing.

Pharma companies are well accustomed to supply chain issues, but how prepared are they for issues impacting access to medical devices?

Clinical trials can be needlessly complex – which impacts the bottom line of trial sponsors. It’s time for change.

Consider CIRM as a bank. We don’t conduct research ourselves: we fund it – and have become the largest dedicated funder of stem cell and gene therapy

Celebrate a decade of pharma innovation with The Medicine Maker’s top features, from cancer vaccines to CRISPR breakthroughs.

Summarizing the updated lessons learned by the European Medicines Agency following the COVID-19 pandemic.